全文获取类型
收费全文 | 18998篇 |
免费 | 1869篇 |
国内免费 | 11篇 |
出版年
2022年 | 144篇 |
2021年 | 279篇 |
2020年 | 165篇 |
2019年 | 194篇 |
2018年 | 276篇 |
2017年 | 252篇 |
2016年 | 420篇 |
2015年 | 759篇 |
2014年 | 791篇 |
2013年 | 1044篇 |
2012年 | 1246篇 |
2011年 | 1243篇 |
2010年 | 841篇 |
2009年 | 751篇 |
2008年 | 1068篇 |
2007年 | 1063篇 |
2006年 | 1002篇 |
2005年 | 1024篇 |
2004年 | 977篇 |
2003年 | 971篇 |
2002年 | 964篇 |
2001年 | 201篇 |
2000年 | 148篇 |
1999年 | 229篇 |
1998年 | 286篇 |
1997年 | 215篇 |
1996年 | 192篇 |
1995年 | 186篇 |
1994年 | 180篇 |
1993年 | 182篇 |
1992年 | 147篇 |
1991年 | 151篇 |
1990年 | 156篇 |
1989年 | 144篇 |
1988年 | 142篇 |
1987年 | 152篇 |
1986年 | 137篇 |
1985年 | 148篇 |
1984年 | 152篇 |
1983年 | 160篇 |
1982年 | 189篇 |
1981年 | 169篇 |
1980年 | 140篇 |
1979年 | 98篇 |
1978年 | 111篇 |
1977年 | 107篇 |
1976年 | 90篇 |
1975年 | 74篇 |
1974年 | 87篇 |
1973年 | 75篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
951.
952.
Chaturvedi P Singh AP Moniaux N Senapati S Chakraborty S Meza JL Batra SK 《Molecular cancer research : MCR》2007,5(4):309-320
MUC4, a transmembrane mucin, is aberrantly expressed in pancreatic adenocarcinomas while remaining undetectable in the normal pancreas. Recent studies have shown that the expression of MUC4 is associated with the progression of pancreatic cancer and is inversely correlated with the prognosis of pancreatic cancer patients. In the present study, we have examined the phenotypic and molecular consequences of MUC4 silencing with an aim of establishing the mechanistic basis for its observed role in the pathogenesis of pancreatic cancer. The silencing of MUC4 expression was achieved by stable expression of a MUC4-specific short hairpin RNA in CD18/HPAF, a highly metastatic pancreatic adenocarcinoma cell line. A significant decrease in MUC4 expression was detected in MUC4-knockdown (CD18/HPAF-siMUC4) cells compared with the parental and scrambled short interfering RNA-transfected (CD18/HPAF-Scr) control cells by immunoblot analysis and immunofluorescence confocal microscopy. Consistent with our previous observation, inhibition of MUC4 expression restrained the pancreatic tumor cell growth and metastasis as shown in an orthotopic mouse model. Our in vitro studies revealed that MUC4-associated increase in tumor cell growth resulted from both the enhanced proliferation and reduced cell death. Furthermore, MUC4 expression was also associated with significantly increased invasiveness (P < or = 0.05) and changes in actin organization. The presence of MUC4 on the cell surface was shown to interfere with the tumor cell-extracellular matrix interactions, in part, by inhibiting the integrin-mediated cell adhesion. An altered expression of growth- and metastasis-associated genes (LI-cadherin, CEACAM6, RAC1, AnnexinA1, thrombomodulin, epiregulin, S100A4, TP53, TP53BP, caspase-2, caspase-3, caspase-7, plakoglobin, and neuregulin-2) was also observed as a consequence of the silencing of MUC4. In conclusion, our study provides experimental evidence that supports the functional significance of MUC4 in pancreatic cancer progression and indicates a novel role for MUC4 in cancer cell signaling. 相似文献
953.
954.
955.
We recently reported the pharmacological screening of a natural products-inspired library of spiroepoxide probes, resulting in the discovery of an agent MJE3 that displayed anti-proliferative effects in human breast cancer cells. MJE3 was found to covalently inactivate phosphoglycerate mutase-1 (PGAM1), a glycolytic enzyme with postulated roles in cancer cell metabolism and proliferation. Considering that MJE3 is one of the first examples of a cell-permeable, small-molecule inhibitor for PGAM1, we pursued a detailed examination of its mechanism and structural requirements for covalent inactivation. MJE3 was found to label PGAM1 on lysine-100, a conserved active site residue implicated in substrate recognition. Structural features of MJE3 important for PGAM1 labeling included two key recognition elements (an indole ring and carboxylic acid), the stereochemical orientation of the spiroepoxide, and presentation of these various binding/reactive groups on a rigid cyclohexane scaffold. Modeling studies of the docked MJE3-PGAM1 complex provide a structural rationale for these stringent requirements. Overall, these studies indicate that a special combination of binding and reactive elements are united in the MJE3 structure to inactivate PGAM1. More generally, our findings provide further evidence that useful pharmacological tools can emerge from screening structurally diverse libraries of protein-reactive probes. 相似文献
956.
957.
Behrens Jane W. Ryberg Marie P. Einberg Heli Eschbaum Redik Florin Ann-Britt Grygiel Wlodzimierz Herrmann Jens Peter Huwer Bastian Hssy Karin Knospina Elina Nomaa Kristiina Oesterwind Daniel Polte Patrick Smoliski Szymon Ustups Didzis van Deurs Mikael Ojaveer Henn 《Biological invasions》2022,24(2):527-541
Biological Invasions - Native to the Ponto-Caspian region, the benthic round goby (Neogobius melanostomus) has invaded several European inland waterbodies as well as the North American Great Lakes... 相似文献
958.
Fernandez M. Pilar Ernst Kacey C. Bron Gebbiena M. Berry Kevin Diuk-Wasser Maria A. Hayden Mary H. 《EcoHealth》2022,19(2):154-158
EcoHealth - Shifts in activity patterns during the COVID-19 pandemic might have impacted the benefits of outdoor activities for mental health. By leveraging an existing mobile application, we... 相似文献
959.
960.